HK1040630A1 - A composition for eliminating undigested fat and reducing cholesterol in the human body the use thereof in the preparation of the medicament. - Google Patents

A composition for eliminating undigested fat and reducing cholesterol in the human body the use thereof in the preparation of the medicament.

Info

Publication number
HK1040630A1
HK1040630A1 HK02102239A HK02102239A HK1040630A1 HK 1040630 A1 HK1040630 A1 HK 1040630A1 HK 02102239 A HK02102239 A HK 02102239A HK 02102239 A HK02102239 A HK 02102239A HK 1040630 A1 HK1040630 A1 HK 1040630A1
Authority
HK
Hong Kong
Prior art keywords
medicament
eliminating
preparation
composition
human body
Prior art date
Application number
HK02102239A
Other versions
HK1040630B (en
Inventor
Jose A Diaz
Eduardo M Naranjo
Original Assignee
Jose A Diaz
Naranjo Aduardo M
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1998/017074 external-priority patent/WO2000010586A1/en
Application filed by Jose A Diaz, Naranjo Aduardo M filed Critical Jose A Diaz
Publication of HK1040630A1 publication Critical patent/HK1040630A1/en
Publication of HK1040630B publication Critical patent/HK1040630B/en

Links

HK02102239.5A 1998-08-18 2002-03-25 A composition for eliminating undigested fat and reducing cholesterol in the human body the use thereof in the preparation of the medicament HK1040630B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1998/017074 WO2000010586A1 (en) 1997-07-07 1998-08-18 Composition and method for eliminating undigested fat and reducing cholesterol in the human body

Publications (2)

Publication Number Publication Date
HK1040630A1 true HK1040630A1 (en) 2002-06-21
HK1040630B HK1040630B (en) 2005-04-22

Family

ID=22267691

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02102239.5A HK1040630B (en) 1998-08-18 2002-03-25 A composition for eliminating undigested fat and reducing cholesterol in the human body the use thereof in the preparation of the medicament

Country Status (4)

Country Link
EP (1) EP1105144A4 (en)
JP (1) JP2002523373A (en)
HK (1) HK1040630B (en)
MX (1) MXPA01001802A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005072750A1 (en) * 2004-01-30 2005-08-11 Otsuka Pharmaceutical Co., Ltd. Composition for inhibting dietary lipid absorption

Also Published As

Publication number Publication date
EP1105144A4 (en) 2003-05-21
MXPA01001802A (en) 2002-04-08
JP2002523373A (en) 2002-07-30
HK1040630B (en) 2005-04-22
EP1105144A1 (en) 2001-06-13

Similar Documents

Publication Publication Date Title
AU2710500A (en) Use of gamma-tocopherol and its oxidative metabolite llu-alpha in the treatment of disease
IL187513A0 (en) Use of (s,s)-reboxetine in the treatment of pain conditions and incontinence
IL114586A (en) Droloxifene for use in the treatment of cardiovascular diseases and pharmaceutical compositions comprising same
GB2323282B (en) Improvements relating to hygiene and medical products
HUP0103236A2 (en) Skin and tissue care and/or treatment agent
ZA9710752B (en) Absorbent articles having cuffs and topsheet with skin care composition disposed thereon.
HUP0004343A2 (en) Tampon for feminine hygiene or medical purposes and process for producing the same
HU9900163D0 (en) Sterol and stanol-esters, preparation and use thereof
GR3036123T3 (en) Phenyl-substituted alkenoylguanidides, process for their preparation, their use as drugs or in diagnostic agents and drugs containing them
GB9919681D0 (en) Improvements relating to medical injectors and skin prickers
AU8905098A (en) Skin care compositions and use
EP1129217A4 (en) Compositions and methods of disease diagnosis and therapy
PL352330A1 (en) Derivatives of pyridopyranoazepine, making of same and use of same in therapy
HK1040055A1 (en) Use of olanzapine and fluoxetine in the preparation of a medicament for the treatment of treatment resistant major depression.
AU9106498A (en) Composition and method for eliminating undigested fat and reducing cholesterol in the human body
HK1026637A1 (en) Compositions for administering taxanes orally to human patients and their use
AU2734995A (en) Phytotherapeutic agent for treatment of skin lesions and morbid changes in the skin and method for its preparation
AU2530199A (en) Targeting immunoreagents useful in therapeutic and diagnostic compositions and methods
ZA981376B (en) Sulfonamide-substituted chromans processes for their preparation their use as medicament or diagnostic aid and medicament comprising them
HK1040630A1 (en) A composition for eliminating undigested fat and reducing cholesterol in the human body the use thereof in the preparation of the medicament.
AU2001296477A1 (en) Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas
IL127350A0 (en) Combinations comprising VX478 zidovudine and/or 1592U89 for use in the treatment of HIV
GB9908059D0 (en) Diagnosis and treatment of diseases
AU3061199A (en) Skin treatment compositions and the use thereof
AUPQ223999A0 (en) Intracellular feedback controls in the diagnosis and treatment of human disease

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20080818